Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Respondents may be grasping
"If you think the MMP will apply a royalty rate against another 1.4 trillion in revenue from the remaining infringers for the next couple years, multiply that by the NDoC award rate of .000125 you get 175 million probably divided by 3 for the Leckrone Family and Moore, Ottesson, and PTSC. That equals 55 million for PTSC for the remainder of the MMP life". <<<<>>>> I think the above should be considered to determine if PTSC should act. The Leckrone family equals say 5 to 15 million divided to probably 5 to 10 people. 15 to 20 million to Moore. 30 million to Ottesson to his company to fu d 50 people. 55 million to PTSC divided by 16,000 shareholders. The dollar amounts are directional only to prove a point and are not meant to be exact. Every single group related to the MMP revenue benefits significantly with the exception of PTSC. Is that a reason to not allow the Leckrone family to win? I say yes ...
Share
New Message
Please login to post a reply